Delivra Health Brands Inc.
DHBUF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $4 | $3 | $3 |
| % Growth | -47.2% | 40.8% | 12.4% | – |
| Cost of Goods Sold | $1 | $2 | $2 | $1 |
| Gross Profit | $1 | $2 | $2 | $1 |
| % Margin | 46% | 53.6% | 50.1% | 47% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | -$0 | $1 | $0 | $0 |
| Operating Expenses | $1 | $2 | $2 | $2 |
| Operating Income | -$0 | $0 | -$0 | -$1 |
| % Margin | -0.7% | 7.1% | -9.1% | -23.5% |
| Other Income/Exp. Net | -$0 | $1 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $1 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | $1 | -$0 | -$1 |
| % Margin | -2.8% | 19.2% | -13.6% | -29.5% |
| EPS | -0.002 | 0.012 | -0.014 | -0.026 |
| % Growth | -117.2% | 190.4% | 48.1% | – |
| EPS Diluted | -0.002 | 0.012 | -0.014 | -0.026 |
| Weighted Avg Shares Out | 31 | 31 | 31 | 31 |
| Weighted Avg Shares Out Dil | 31 | 31 | 31 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | -$0 | $0 | $0 |
| Depreciation & Amortization | $0 | -$0 | $0 | $0 |
| EBITDA | $0 | $1 | -$0 | -$0 |
| % Margin | 0.3% | 14.9% | -1% | -14.1% |